Epigenetic drug screen identifies the histone deacetylase inhibitor NSC3852 as a potential novel drug for the treatment of pediatric acute myeloid leukemia.

Autor: Wiggers, Caroline R.M., Govers, Anita M.A.P., Lelieveld, Daphne, Egan, David A., Zwaan, C. Michel, Sonneveld, Edwin, Coffer, Paul J., Bartels, Marije
Zdroj: Pediatric Blood & Cancer; Aug2019, Vol. 66 Issue 8, pN.PAG-N.PAG, 1p
Databáze: Complementary Index
Externí odkaz: